Click a link below to view the mailing archive as if it had been sent to you.
2017-04-29 12:15 | | These 7 Drugmakers Relied on Price Hikes for 100% of Their Earnings Growth in 2016 and more... |
2017-04-28 12:15 | | Sarepta CEO Exits Along With a Sanofi Director, So Let's Speculate About a Possible Deal and more... |
2017-04-28 00:15 | | Three Biotechs Enter…One Biotech Gains and more... |
2017-04-27 12:15 | | AbbVie stock surges 1.5% after first-quarter profit, revenue beats and more... |
2017-04-27 00:15 | | Amgen first-quarter profit exceeds Street estimates on lower costs and more... |
2017-04-26 12:15 | | J&J, Bayer face first jury trial over blockbuster Xarelto's bleedings risks and more... |
2017-04-26 00:15 | | Regeneron’s CEO, CSO saw their compensation slashed in ’16 — but it’s still a jaw-dropping sum and more... |
2017-04-25 12:15 | | Novartis beats 1Q profit forecasts and more... |
2017-04-25 00:15 | | J&J, Bayer Accused of Hiding Blood-Thinning Drug's Flaws and more... |
2017-04-24 12:15 | | Becton Dickinson to acquire Bard in $24B deal and more... |
2017-04-23 12:15 | | The 10 hottest medtech startups of 2017 and more... |
2017-04-23 00:15 | | Bristol-Myers NASH drug reduces liver fat in midstage study and more... |
2017-04-21 12:15 | | GSK told to pay $3M for Chicago attorney's suicide while on generic Paxil and more... |
2017-04-21 00:15 | | Biopharma opening up to new ways of partnering on R&D and more... |
2017-04-20 12:15 | | Abbott CEO Upbeat Despite Ongoing Merger Headaches and more... |
2017-04-20 00:15 | | Report: Price hikes are still driving pharma's earnings growth. Who's most at risk? and more... |
2017-04-19 12:15 | | Abbott's profit rises 33 percent after St. Jude Medical deal and more... |
2017-04-19 00:15 | | FDA hits the ground running with 12 first-quarter 2017 drug approvals and more... |
2017-04-18 12:15 | | Johnson & Johnson tops 1Q profit forecasts, but net dips and more... |
2017-04-18 00:15 | | How Pfizer Inc. Makes Most of Its Money and more... |
2017-04-17 12:15 | | Chasing a big payday, new drugmakers slightly favor solo launches: Report and more... |
2017-04-15 12:15 | | Payer snubs PTC's Emflaza, signaling pricing trouble ahead of launch and more... |
2017-04-14 12:15 | | Eli Lilly and Incyte say FDA failed to approve their rheumatoid arthritis drug and more... |
2017-04-14 00:15 | | Novartis' Gilenya patent loss sets MS market up for battle with early generics and more... |
2017-04-13 12:15 | | Bristol-Myers to license two drugs to Biogen, Roche and more... |
2017-04-13 00:15 | | Organovo Holdings CEO Leaves: Should Investors Be Worried? and more... |
2017-04-12 12:15 | | 3 Big Drugmakers Most Likely to Buy Incyte and more... |
2017-04-11 12:15 | | Clinical trial enrollment gets harder as patient populations shrink and more... |
2017-04-11 00:15 | | Stada's patience pays off as Cinven, Bain clinch big $5.6B buyout bid and more... |
2017-04-10 12:15 | | Roche unit Genentech takes on Pfizer with new lung cancer data and more... |
2017-04-10 00:15 | | 3 Big Biotech Stocks With Big-Time Catalysts and more... |
2017-04-09 00:15 | | Gilead Hep C Drugs Get Supplemental FDA Nod and more... |
2017-04-07 12:15 | | FDA nixes Merck’s shot at getting Januvia cardio safety data onto the label and more... |
2017-04-07 00:15 | | 23andMe Rides Again: FDA Clears Genetic Tests To Predict Disease Risk and more... |
2017-04-06 12:15 | | Allergan To Test Botox For Depression Despite Mixed Results and more... |
2017-04-06 00:15 | | Intuitive Surgical shares rise amidst takeover rumors and more... |
2017-04-05 00:15 | | Racing in lung cancer again (or still), Merck and BMS expand Incyte combo trials and more... |
2017-04-04 12:15 | | Mallinckrodt to settle oxycodone diversion case for $35M with Justice Department and more... |
2017-04-03 12:15 | | Pfizer's Ibrance Gets FDA Approval for Breast Cancer and more... |
2017-04-01 12:15 | | Pharma's most-valuable brands? J&J, Pfizer and Merck. Valeant, not so much and more... |
2017-04-01 00:15 | | FDA Approves Astra's Lung Cancer Drug and more... |